Clinical trial
Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous…
NCT00443261 · University of Kansas Medical Center, Other · Terminated
Key facts
| NCT number | NCT00443261 |
|---|---|
| Title | Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck |
| Official title | Phase I Study of Azacitidine in Combination With Cisplatin Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck |
| Lead sponsor | University of Kansas Medical Center, Other |
| Collaborators | Celgene Corporation Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Squamous Cell Carcinoma |
| Intervention type | Drug |
| Interventions | Azacitidine, Cisplatin |
| Enrollment | 1 |
| Start date | Feb 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Mar 5, 2007 |
| Last update posted | Feb 27, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: